These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2905503)

  • 21. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
    Segal DS; Kuczenski R
    Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
    Jackson DM; Ross SB; Larsson LG
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines.
    Martin-Iverson MT
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):281-5. PubMed ID: 1683687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
    Martin GE; Williams M; Pettibone DJ; Zrada MM; Lotti VJ; Taylor DA; Jones JH
    J Pharmacol Exp Ther; 1985 May; 233(2):395-401. PubMed ID: 2987478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.
    Gomez-Mancilla B; Bédard PJ
    Exp Neurol; 1992 Aug; 117(2):185-8. PubMed ID: 1354166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine.
    Filip M; Frankowska M; Zaniewska M; Przegaliński E; Muller CE; Agnati L; Franco R; Roberts DC; Fuxe K
    Brain Res; 2006 Mar; 1077(1):67-80. PubMed ID: 16516871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral sensitization and tolerance to the D2 agonist RU 24213: dissociation between several behavior patterns in mice.
    Tirelli E; Jodogne C
    Pharmacol Biochem Behav; 1993 Mar; 44(3):627-32. PubMed ID: 8095724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rate of behavioral tolerance development to repeated lipopolysaccharide treatments depends upon the time of injection during the light-dark cycle: a multivariable examination of locomotor activity.
    Franklin AE; Engeland CG; Kavaliers M; Ossenkopp KP
    Behav Brain Res; 2007 Jun; 180(2):161-73. PubMed ID: 17433456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
    Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
    Culver KE; Szechtman H
    Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W; Tepper PG; Dijkstra D; Stoelwinder H; Grol CJ; Westerink BH; Horn AS
    Eur J Pharmacol; 1991 Jun; 199(2):145-51. PubMed ID: 1683287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.
    Timmerman W; De Vries JB; Westerink BH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):650-4. PubMed ID: 1982893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.
    Broadbent J; Kampmueller KM; Koonse SA
    Alcohol; 2005 Feb; 35(2):137-48. PubMed ID: 15963427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.
    Luquin MR; Obeso JA; Laguna J; Guillén J; Martínez-Lage JM
    Eur J Pharmacol; 1993 Apr; 235(2-3):297-300. PubMed ID: 7685291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intra-accumbens administration of dopamine agonists on stress-induced behavioural deficit.
    Płaźnik A; Stefański R; Puciłowski O; Kostowski W
    J Pharm Pharmacol; 1990 Feb; 42(2):79-84. PubMed ID: 1972406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.